Anthony D. Kolton:

President and CEO

Anthony Kolton is President and the business Founder of RMS. Mr. Kolton has had extensive experience and a successful track record in both start-ups and technology companies. He founded Logical Information Machines (LIM) in 1988 with three other partners, each putting up $1,000 in capital for a total $4,000 in capital and, under his direction as President, turned the company into a business with revenues over $20 million per year. He also invented the “Market Information Machine”, a tool that allows you to ask any question about any market and obtain an instant answer, which was the flagship product of LIM. In December 2009, LIM was sold to Morningstar for over $50 million. 

Mr. Kolton earned a Bachelor of Science degree in Accounting from DePaul University and subsequently his CPA certificate. He also earned both a Masters in Taxation degree and a Juris Doctor degree in law from DePaul University, after attending both programs simultaneously at night.

Dr. Jon Odorico is the Chief Scientific Officer and the Scientific Founder of RMS. He is responsible for the overall scientific direction of the Company. Dr. Odorico is also a Professor, Department of Surgery, Division of Organ Transplantation at the University of Wisconsin-Madison School of Medicine and Public Health in Madison, WI. Dr. Odorico is certified by the American Board of Surgery and specializes in pancreas transplants, islet cell transplants and multi-organ transplants. In addition, he performs general surgery procedures on transplant patients. He currently serves as Director of both the Pancreas and Islet Transplantation Programs. He received his B.S. degree in the field of chemistry from Duke University in 1983 and his medical degree from New York University, School of Medicine in 1987. He then completed training in General Surgery and Transplantation at the University of Pennsylvania and the University of Wisconsin, respectively. 

Jon S. Odorico, MD, FACS

Scientist, Co-Founder

He has received numerous awards in his research field of study, including the National Research Service Award from the National Institutes of Health, the Jonathon E. Rhoads Research Award from the Harrison Department of Surgical Research, at University of Pennsylvania School of Medicine, the Best Abstract Award from OrthoBiotech Transplant Fellows Workshop, Howard Hughes Medical Institute Faculty Development Award, the Vilas Associate Award from the University of Wisconsin and the Fujisawa Faculty Development Award from American Society of Transplant Surgeons. He has worked in the field of stem cell research and diabetes for over 15 years and is a key thought leader in the field as evidenced by numerous peer-reviewed publications and book chapters, as well as service on grant review boards. Dr. Odorico co-authored the textbook, Human Embryonic Stem Cells ©2005, Taylor and Francis, ISBN: 1859962785. Over the years he has worked with Dr. James Thomson, the University of Wisconsin stem cell pioneer, collaborating with him on grants and publications. Dr. Odorico is also a member of the Stem Cell and Regenerative Medicine Center at the University of Wisconsin and regularly collaborates with many stem cell scientists worldwide. 

Dr. Dena E. Cohen is the Chief Scientific Officer of RMS. She is responsibe for direction of RMS’s research program, oversees the research team, and leads product and process development for the company. She received a B.S. degree from the Massachusetts Institute of Technology in the field of biology in 1998, and a PhD degree from Harvard University in the field of genetics in 2005. She subsequently completed a Master of Liberal Arts degree in the field of management at the Harvard University Extension School. Her scientific research has been published in a variety of prestigious journals including Genes & Development, Developmental Cell, Nature Medicine, and the Journal of the American Society of Nephrology.

Dena E Cohen, PhD, ALM

Chief Scientific Officer

Tom Joyce is Vice President of Corporate Development and Administration of Regenerative Medical Solutions. In this role he manages day-to-day operations of finance, marketing and logistics for RMS. He previously was a key market researcher with Logical Information Machines specializing in developing data, conducting research and streamlining financial operations. Mr. Joyce was named to the Dean’s List in all semesters and graduated Summa Cum Laude with a degree in Finance and Banking from the Trulaske College of Business at the University of Missouri-Columbia.

Thomas P. Joyce:

Vice President

Gary Gorman is a founding partner of RMS. Mr. Gorman is President and CEO of Gorman & Company. The company currently employs more than 120 people, producing 300 new apartments per year through its in-house general contracting division. As President and CEO, Gary has broad responsibility for all operations of the company. Gary Gorman received an Economics degree from the University of Wisconsin in 1977 and graduated from the UW Law School in 1980. He practiced real estate and securities law at a Madison-based firm for four years before founding Gorman & Company in 1984. 

Gary J. Gorman

Founding Partner